Psychedelic Business Spotlight: October 1, 2021

This week in psychedelic business news: more evidence supporting ketamine for depression; a new use for MDMA; Lobe Sciences makes a leap in treating PTSD; Delix raises big bucks; and BetterLife Pharma patents solution for cluster headaches.

Psychedelic Business Spotlight: October 1, 2021